Description
Pharmacological action of
Marbofloxacin belongs to the group of fluoroquinolones and has a wide spectrum of bactericidal action based on the suppression of bacterial DNA replication.
Marbofloxacin is active against gram-positive and gram-negative microorganisms, including Escherichia coli, Salmonella typhimurium, Citrobacter freundii, Enterobacter cloacae, Serratia marcescens, Morganella morganii, Proteus spp, Klebsiella spp, Shigella spp, Pasteurella spp, Haemophilus spp, Moraxella spp, Pseudomonas spp, Brucellococis canis et al.
After oral administration of Marfloxin, marbofloxacin is well absorbed in the gastrointestinal tract and penetrates into all organs and tissues of the body. Bioavailability of almost 100%.
The maximum concentration in the blood is reached after 2.0 hours, period
After oral administration of Marfloxin, marbofloxacin is well absorbed in the gastrointestinal tract and penetrates into all organs and tissues of the body. Bioavailability of almost 100%.
The maximum concentration in the blood is reached after 2.0 hours, period
After oral administration of Marfloxin, marbofloxacin is well absorbed in the gastrointestinal tract and penetrates into all organs and tissues of the body. Bioavailability of almost 100%.
The maximum concentration in the blood is reached after 2.0 hours, periodthe half-life in dogs is 14 hours, in cats 10 hours.
Marbofloxacin is excreted from the body of animals mainly in unchanged form with urine and bile.
Marfloxin tablets according to the degree of exposure to the body refers to low-hazard substances (hazard class 4 according to GOST 12.1.007-76).
Indications
Assign for the treatment of dogs and cats with diseases of the respiratory system, gastrointestinal tract and urogenital system, infections of the skin, soft tissues and otitis media, infected wounds and other diseases of the bacterial and mycoplasma etiology, the causative agents of which are sensitive to marbofloxacin.
Contraindications
Increased individual sensitivity to the components of the drug.
Do not use the drug in kittens younger than 2 months old, puppies under 12 months old (puppies of large breeds younger than 18 months old), as well as animals with lesions of the central nervous system.
Composition
Marfloxin tablets as an active ingredient contains 80 mg marbofloxacin in one tablet, and excipients – lactose monohydrate, povidone, crospovidone, magnesium stearate, meat flavoring, hydrogenated castor oil, yeast silica powder, silicon dioxide yeast.
Dosage and administration
The drug is administered to animals once a day, individually in a crushed form with food, or forcibly introduced to the root of the tongue in a daily dose of 2 mg / kg body weight of the animal.
The duration of treatment for dogs is from 5 to 40 days for infections of the skin and soft tissues, from 10 to 28 days for diseases of the genitourinary system, and from 7 to 21 days for diseases of the respiratory system.
In case of overdose in animals, disturbances in the activity of the nervous system can be observed. The treatment is symptomatic.
Features of the drug during its first use and withdrawal have not been established.
Avoid skipping the next dose of the drug, as this can lead to a decrease in therapeutic efficacy. If one dose is missed, the use of the drug is resumed in the same dosage and in the same way.
Side effects
When using the drug in the recommended dose, no side effects were found in dogs and cats. Gastrointestinal symptoms, such as vomiting and softening of the stool, which pass after treatment and do not require discontinuation of the drug.
Storage conditions
In the manufacturer s sealed packaging, in a dry, dark place and out of the reach of children and animals, separately from food and feed at a temperature of 0 ° C to 25 ° C.
Shelf life
2 years.
Active ingredient
Marbofloxacin
Dosage form
tablets
